End-stage renal disease : CMS should monitor access to and quality of dialysis care promptly after implementation of new bundled payment system : report to congressional requesters.

Author/creator United States
Format Electronic
Publication Info[Washington D.C.] : U.S. Govt. Accountability Office, [2010]
Description1 online resource (iii, 66 p.) : ill., charts
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo3078
Subjects

Variant title End stage renal disease : Centers for Medicare & Medicaid Services (CMS) should monitor access to and quality of dialysis care promptly after implementation of new bundled payment system
Portion of title CMS should monitor access to and quality of dialysis care promptly after implementation of new bundled payment system
Contents Letter--Appendix I objectives, scope, and methodology--Appendix II GAO data collection instrument on dose of dialysis related drugs--Appendix III Medicare expenditures for injectable ESRD drugs by demographic characters--Appendix IV detailed results from data collection instrument on dose of dialysis-related drugs--Appendix V comments from the centers of Medicare & Medicaid services--Appendix VI GAO contact and staff acknowledgments--Tables--Figures.
General noteTitle from PDF title screen (GAO, viewed July 8, 2010).
General note"March 2010."
General note"GAO-10-295."
General noteGPO Cataloging Record Distribution Program (CRDP).
Bibliography noteIncludes bibliographical references.
Technical rpt numberGAO-10-295
GPO item number0546-D (online)
Govt. docs number GA 1.13:GAO-10-295

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available